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Transarterial embolization of a post-biopsy portal vein pseudoaneurysm using
N-butyl cyanoacrylate
Ji Hoon Shin,1,* Do Hyun Park,2 Hyun-Ki Yoon1
a b s t r a c t
We report the case of a 71-year-old man with hemobilia after a postbiopsy portal vein pseudoaneurysm in segment VI of the liver, which was treated with
successful transarterial embolization. Because an arterioportal ﬁstulous tract was visible using ﬂuoroscopic imaging, N-butyl cyanoacrylate (NBCA) was
successfully injected from the hepatic artery into the portal vein, with subsequent exclusion of the pseudoaneurysm. Follow-up computed tomography
scans obtained 2 days after embolization showed an NBCA cast within the portal vein and no further opaciﬁcation of the pseudoaneurysm.
Copyright  2013, Society of Gastrointestinal Intervention. Published by Elsevier.
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Portal venous pseudoaneurysms have rarely been described in
the medical literature.1–4 Unlike an aneurysm, which has three
intact layers in the vascular wall, a pseudoaneurysm is a pulsatile
hematoma caused by blood leaks through a tear or disruption in the
vessel wall. As with arterial pseudoaneurysms, portal venous
pseudoaneurysms have the potential to rupture and thus cause
severe bleeding; therefore, they should be considered an imminent
cause of hemorrhage.
Treatment of impending or ongoing portal venous hemorrhage
depends on the clinical status, associated vascular injury or
abnormality, sites of bleeding, and availability of clinical specialists.
Among the reported casesof post-traumatic, intrahepatic portal vein
pseudoaneurysms, one case of portal vein embolization through
the ileocecal vein and under laparotomy has been reported.2
We report a case of successful transarterial embolization of an
intrahepatic portal vein pseudoaneurysm following percutaneous
biopsy. N-Butyl cyanoacrylate (NBCA) was successfully injected
through an arterioportal shunt, from the hepatic artery into the
portal vein, excluding the pseudoaneurysm.
Case report
A 71-year-oldmale had been diagnosedwith a dysplastic nodule
in segment VI of the liver 7 years previously, for which he had
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magnetic resonance follow-up session, a biopsy was recommended
as the diameter of the nodule had increased from 2 cm to 2.4 cm.
The patient underwent an uneventful percutaneous ultrasound-
guided biopsy of the nodule, but 2 days after the biopsy he expe-
rienced a sudden onset of epigastric pain for which he was seen in
our emergency room.
Pre- and postcontrast computed tomography (CT) scans ob-
tained 3 days after the biopsy showed a pseudoaneurysmwithin the
biopsied nodule and hematoma within the biliary tree. Hemobilia
was conﬁrmed and removed on endoscopic retrograde chol-
angiopancreatography performed on the same day. There was no
change in the patient’s hemoglobin level. As the pseudoaneurysm
seemed to have originated from the portal vein and the patient’s
epigastric pain had resolved, conservative management was used.
However, as dynamic CT scans obtained 10 days after the biopsy
showed an increase in diameter of the pseudoaneurysm from
10 mm to 13 mm (Fig. 1), it was decided to treat the pseudoaneur-
ysm, since although it was apparently attached to the adjacent
portal vein, a possible hepatic artery origin had to be ruled out.
Hepatic arteriograms showed an arterioportal shunt with
pseudoaneurysm opaciﬁcation and a probable ﬁstulous tract con-
necting the hepatic artery and the portal vein (Fig. 2A and B). The
micro-guidewire could be passed through the tract, although a
microcatheter (2.0 Fr Progreat; Terumo, Tokyo, Japan) could not
(Fig. 2C). The tip of the microcatheter lay at the entrance of the
ﬁstulous tract, and a test contrast injection showed visualization ofnter, South Korea
niversity of Ulsan College of Medicine, Asan Medical Center, 388-1, Pungnap-2dong,
vier. Open access under CC BY-NC-ND license.
Fig. 1. Axial (A) and coronal (B) arterial-phase computed tomography scans obtained 10 days after biopsy of the mass in segment VI of the liver, showing early opaciﬁcation of the
right posterior inferior branch of the portal vein and a pseudoaneurysm (arrows) attached to the adjacent portal vein (arrowheads).
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such as NBCA, was considered for use in this microcatheter-
inaccessible embolization.
NBCA (Histoacryl; B. Braun, Melsungen, Germany) was mixed
with iodized oil (Lipiodol; Andre Guerbet, Aulnay-Sous-Bois,Fig. 2. Selective right hepatic arteriogram (A) and spot radiograph (B) showing an arterioport
(arrowheads in B). A spot radiograph (C) shows passage of the micro-guidewire through the p
perhapsdue to the tightnessof the tract.A spot radiograph (D)obtainedafterN-butylcyanoacryl
as the adjacent hepatic artery (arrows) and portal vein (long arrows). A completion arteriogramFrance) in a 1:2 ratio, and dextrose 5% in water solution was used
to ﬂush the microcatheter to prevent premature polymerization of
the mixture with residual blood or saline inside the microcatheter
before injecting the NBCA mixture. The NBCA mixture was then
injected using a 1-mL syringe guided by ﬂuoroscopic monitoring toal shunt with pseudoaneurysm opaciﬁcation. A probable ﬁstulous tract is also visualized
robable ﬁstulous tract (arrowheads). However, the microcatheter could not be advanced,
ate (NBCA)embolizationshowsanNBCAcastﬁlling theﬁstulous tract (arrowheads) aswell
(E) shows no further visualization of the portal vein or the pseudoaneurysm.
Fig. 3. Axial (A) and coronal (B) arterial-phase computed tomography scans obtained 2 days after embolization, showing the N-butyl cyanoacrylate (NBCA) cast (arrowheads) within
the portal vein and no opaciﬁcation of the pseudoaneurysm (arrows in B). A small amount of NBCA is noted within the lumen of the pseudoaneurysm (arrow in A).
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riogram obtained upon completion of the procedure showed
complete exclusion of the pseudoaneurysm (Fig. 2E).
Liver-related enzymes such as aspartate transaminase, alanine
transaminase, and bilirubin did not increase after embolization.
Follow-up CT scans obtained 2 days following embolization
showed an NBCA cast within the portal vein and no further opa-
ciﬁcation of the pseudoaneurysm (Fig. 3). The patient was in a good
condition at the time of writing this report, 10 months following
embolization.
Discussion
Percutaneous transhepatic procedures and trauma can produce
arterioportal ﬁstulas,5 and traumatic portal venous pseudoaneur-
ysms are also possible, although they have rarely been reported.1,2
Locating a portal vein pseudoaneurysm or the area where it is
bleeding is very important. When it is extrahepatic, it is usually
fatal, and stenting with embolization of the pseudoaneurysm or
surgery have both been reported.3,4 However, when it is an intra-
hepatic pseudoaneurysm, conservative management or successful
direct portal vein embolization using the ileocecal vein approach
under laparotomy have both been applied.1,2
The therapeutic options have evolved from surgical manage-
ment to an endovascular, less invasive approach for treating
vascular pseudoaneurysms, which has dramatically decreased the
morbidity and mortality rates.4
Interventional radiologists can access the portal vein using a
direct, percutaneous approach to the portal vein or the transjugular
intrahepatic portosystemic shunt (TIPS) tract via the jugular vein if
there is no communication between the portal vein and the hepatic
artery. In our patient, the arterioportal ﬁstulous tract was visible
using ﬂuoroscopic imaging, enabling embolization of the portal
vein pseudoaneurysm through the ﬁstulous tract from the hepatic
artery. This unique approach has not been previously reported. If
there is suspected communication between the portal vein and the
hepatic artery, for example early opaciﬁcation of the portal vein, the
arterial approach should be used ﬁrst to determine possibleaccessible communication between the two vessels and to search
for associated hepatic arterial injury. If the arterial approach is not
possible, the direct percutaneous approach would be the next
option.
NBCA is advantageous for its high accessibility to the target site,
even to the distal small branches where access with a micro-
catheter is difﬁcult because of its conformable nature. NBCA also
offers immediate occlusion of the vessel compared to the more
commonly used microcoils.6 In our patient, the ﬁstulous tract was
too tight to permit advancement of the microcatheter. In all prac-
ticality, secure embolization of the pseudoaneurysm arising from
the portal vein could not be performed with microcoils or gelfoam
particles.
In summary, we present a case of successful transarterial embo-
lization of an intrahepatic portal vein pseudoaneurysm following
percutaneous biopsy. A hepatic arterial approach and use of NBCA
should, therefore, be considered as a treatment optionwhen there is
communication between the portal vein and the hepatic artery.
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